View BPC-157 Purity (HPLC)
keep out of reach of young children contra-indication If you have a medical condition, are pregnant, lactating, or trying to conceive, are under the age of 18, or are taking medications, consult your health care practitioner before using this product
Pregnancy and breastfeeding: No safety data exists for use during pregnancy or lactation
Co-administration could lead to excessive down-regulation of mTORC1, potentially blunting necessary cellular repair, immune function, and wound healing
N-acetyl cysteine in ovulation induction of PCOS women underwent intrauterine insemination: an RCT
GLP-1 medicines and the treatment of obesity GLP-1RAs led to weight loss investigations, with liraglutide 3 mg daily approved for weight loss in 2014, followed by semaglutide 2.4 mg weekly in 2021, and tirzepatide in 2023